Patents by Inventor Mark Travi

Mark Travi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11554137
    Abstract: A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when applied over blood, provides an antimicrobial against planktonic microorganisms and biofilms in the wound. The resin is also capable, when applied in sufficient quantities, of providing a continuing and persistent antimicrobial against planktonic microorganisms and biofilms through dehydration and ion exchange with cations present in the blood and other body fluids. When the resin has a concentration of at least 26 mg/ml, it provides a >3 log reduction in biological activity of MRSA, MRSE and Pseudomonas aeruginosa.
    Type: Grant
    Filed: January 3, 2014
    Date of Patent: January 17, 2023
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, John Alfred Thompson, Talmadge Kelly Keene, Mark Travi
  • Publication number: 20220192891
    Abstract: A flexible hemostatic pad formed from a hemostatic powder, which may contain a hydrophilic polymer such as a cation ion exchange resin, compressed onto or into a velvet-like backing substrate is provided for the control of bleeding at a wound site.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 23, 2022
    Inventors: Kurt Vadelund, Talmadge Kelly Keene, Kenneth Wiglund, Mark Travi
  • Publication number: 20220151930
    Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.
    Type: Application
    Filed: December 30, 2021
    Publication date: May 19, 2022
    Inventors: Kurt Vadelund, Talmadge Kelly Keene, Mark Travi
  • Patent number: 11241386
    Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: February 8, 2022
    Assignee: Biolife, L.L.C.
    Inventors: Kurt Vadelund, Talmadge Kelly Keene, Mark Travi
  • Publication number: 20200253874
    Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.
    Type: Application
    Filed: February 13, 2019
    Publication date: August 13, 2020
    Inventors: Kurt Vadelund, Kelly Keene, Mark Travi
  • Patent number: 9928627
    Abstract: An approach is provided for grouping and de-overlapping items in a user interface. A display manager determines one or more items for rendering in a user interface. The display manager then causes, at least in part, a determination of one or more rendering locations for one or more representations of the one or more items based, at least in part, on location information associated with the one or more items. The display manager further causes, at least in part, a grouping, a de-overlapping, or a combination thereof of the one or more representations based, at least in part, on an overlapping of the one or more rendering locations. The display manager also causes, at least in part, a rendering of the one or more representations in the user interface based, at least in part, on the grouping, the de-overlapping, or a combination thereof.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: March 27, 2018
    Assignee: Nokia Technologies Oy
    Inventors: Mark Travis Fulks, Ashok Ravula, Kenneth Walker, Bamidele Adetokunbo, Srikanth Challa, Christophe Marle, Aaron Licata, Pankaj Kumar Jain, Matthew Johnson
  • Patent number: 9877728
    Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: January 30, 2018
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 9827409
    Abstract: A tattooing device is designed for ingraining a design on the skin. The tattooing device includes an electric drive motor with a rotatable motor pin. The motor pin defines an axis of rotation. A rotatable actuator cam is operatively connected to the motor pin, and comprises a cam post axially offset from the motor pin and the axis of rotation. An elongated drive shaft is operatively connected to the cam post, such that rotation of the actuator cam effects simultaneous substantially linear reciprocating movement of the drive shaft. A needle assembly is operatively connected to the drive shaft, and adapted for carrying a pointed tattooing needle for penetrating the skin.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: November 28, 2017
    Assignee: Inline Tattoo Machines, LLC
    Inventors: Mark Travis Evans, Grady Lee Dudding, Jr.
  • Publication number: 20170172582
    Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Application
    Filed: March 2, 2017
    Publication date: June 22, 2017
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 9585671
    Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: March 7, 2017
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Publication number: 20160206298
    Abstract: A combination radial arm band and hemostatic material preferably including potassium ferrate and a cation ion exchange resin in powder or granular form (WOUNDSEAL) or formed into a solid tablet (STATSEAL) and having improved topical effectiveness in the arresting of blood flow from a puncture wound into the radial artery made during transradial diagnostic or interventional catheterization procedures. The combination reduces time and pressure needed to achieve hemostasis and decreases arterial damage as compared to use of a radial arm band alone. In one aspect of this disclosure, careful limitation of applied force and time of applied force against the STATSEAL tablet reduces likelihood of harm to the radial artery while minimizing time to achieve hemostasis.
    Type: Application
    Filed: January 21, 2016
    Publication date: July 21, 2016
    Inventors: Talmadge Kelly Keene, Timothy J. Kelly, John Tifton Fordham, Mark Travi
  • Patent number: 9245051
    Abstract: An approach is provided for conducting a search based on an extraction of a search term from available sensor data. The approach involves determining sensor data associated with at least one device, the sensor data determined from among a plurality of available data modes. The approach also involved processing and/or facilitating a processing of the sensor data to cause, at least in part, an extraction of one or more search terms for at least one query. The approach further involves determining one or more results of the at least one query based, at least in part, on context information associated with the at least one device, user profile information associated with the at least one device, or a combination thereof.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: January 26, 2016
    Assignee: NOKIA TECHNOLOGIES OY
    Inventors: Aaron Licata, Adetokunbo Bamidele, Mark Travis Fulks
  • Publication number: 20150356763
    Abstract: An approach is provided for grouping and de-overlapping items in a user interface. A display manager determines one or more items for rendering in a user interface. The display manager then causes, at least in part, a determination of one or more rendering locations for one or more representations of the one or more items based, at least in part, on location information associated with the one or more items. The display manager further causes, at least in part, a grouping, a de-overlapping, or a combination thereof of the one or more representations based, at least in part, on an overlapping of the one or more rendering locations. The display manager also causes, at least in part, a rendering of the one or more representations in the user interface based, at least in part, on the grouping, the de-overlapping, or a combination thereof.
    Type: Application
    Filed: June 17, 2015
    Publication date: December 10, 2015
    Inventors: Mark Travis FULKS, Ashok RAVULA, Kenneth WALKER, Bamidele ADETOKUNBO, Srikanth CHALLA, Christophe MARLE, Aaron LICATA, Pankaj Kumar JAIN, Matthew JOHNSON
  • Publication number: 20150257766
    Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Application
    Filed: May 21, 2015
    Publication date: September 17, 2015
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 9087412
    Abstract: An approach is provided for grouping and de-overlapping items in a user interface. A display manager determines one or more items for rendering in a user interface. The display manager then causes, at least in part, a determination of one or more rendering locations for one or more representations of the one or more items based, at least in part, on location information associated with the one or more items. The display manager further causes, at least in part, a grouping, a de-overlapping, or a combination thereof of the one or more representations based, at least in part, on an overlapping of the one or more rendering locations. The display manager also causes, at least in part, a rendering of the one or more representations in the user interface based, at least in part, on the grouping, the de-overlapping, or a combination thereof.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 21, 2015
    Assignee: NOKIA TECHNOLOGIES OY
    Inventors: Mark Travis Fulks, Ashok Ravula, Kenneth Walker, Bamidele Adetokunbo, Srikanth Challa, Christophe Marle, Aaron Licata, Pankaj Jain, Matthew Johnson
  • Publication number: 20150147392
    Abstract: A method of arresting blood flow from a bleeding wound including the steps of (1) providing a solid hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery onto a bleeding wound, the tablet defining a proximal portion and a distal portion, (2) applying the proximal portion against the bleeding wound to improve the rate of adhesion to a bleeding wound surface, and then (3) applying pressure against the tablet over the wound site. After the seal is formed from the interaction of blood or exudates with the proximal portion of the tablet, the distal portion of the tablet delaminates from the proximal portion to form a reservoir to stop further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Application
    Filed: January 27, 2015
    Publication date: May 28, 2015
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 9039667
    Abstract: A method of arresting blood flow from a bleeding wound including the steps of (1) providing a solid hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery onto a bleeding wound, the tablet defining a proximal portion and a distal portion, (2) applying the proximal portion against the bleeding wound to improve the rate of adhesion to a bleeding wound surface, and then (3) applying pressure against the tablet over the wound site. After the seal is formed from the interaction of blood or exudates with the proximal portion of the tablet, the distal portion of the tablet delaminates from the proximal portion to form a reservoir to stop further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: May 26, 2015
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 8979726
    Abstract: A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: March 17, 2015
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 8961479
    Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.
    Type: Grant
    Filed: March 19, 2013
    Date of Patent: February 24, 2015
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Publication number: 20140120052
    Abstract: A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when applied over blood, provides an antimicrobial against planktonic microorganisms and biofilms in the wound. The resin is also capable, when applied in sufficient quantities, of providing a continuing and persistent antimicrobial against planktonic microorganisms and biofilms through dehydration and ion exchange with cations present in the blood and other body fluids. When the resin has a concentration of at least 26 mg/ml, it provides a >3 log reduction in biological activity of MRSA, MRSE and Pseudomonas aeruginosa.
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicant: BIOLIFE, LLC
    Inventors: JOHN HEN, JOHN ALFRED THOMPSON, TALMADGE KELLY KEENE, MARK TRAVI